Kronox Lab Sciences IPO Day 2: Should You Subscribe or Not?

Impressive Demand: Kronox Lab Sciences IPO witnessed an enthusiastic response on its first day, with a subscription rate of 11.10 times, reflecting strong market interest.

QIB Participation: Qualified Institutional Buyers (QIBs) also demonstrated significant interest, with subscriptions reaching 1.11 times.

Non-Institutional Investors Lead: Non-institutional investors made the largest share of the offering, subscribing 19.97 times their quota.

Strong Retail Interest: Retail investors showed robust participation, subscribing 13 times their allotted portion, indicating confidence in the company’s potential 

Price Band: The IPO price band is attractively set between ₹129 and ₹136 per equity share, making it accessible for a broad range of investors.

 Anchor Investors: Anchor investors have already contributed ₹39.04 crore, underscoring their confidence in Kronox Lab Sciences.

High Purity Speciality Chemicals: Kronox Lab Sciences is known for its high purity speciality fine chemicals, serving various industries and exporting to 20 countries.

 Revenue Growth: The company has demonstrated consistent revenue growth, which is a positive indicator for potential investors.

Listing Gains: Hensex Securities recommends subscribing for potential listing gains and a long-term investment perspective.

Subscription Window: The subscription period for the IPO started on Monday, June 3, and will conclude on Wednesday, June 5. Make sure to act promptly to secure your investment opportunity.